| RS1684008469 |
CHRNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal multiple pterygium syndrome, Myasthenic syndrome |
| RS1684009556 |
CHRNA1
|
Health Risk |
Pathogenic |
Lethal multiple pterygium syndrome, Lethal multiple pterygium syndrome |
| RS1684052200 |
CHRNA1
|
Health Risk |
Pathogenic |
Lethal multiple pterygium syndrome, Lethal multiple pterygium syndrome |
| RS16840561 |
CFHR1
|
Health Risk |
Likely pathogenic |
— |
| RS1684057503 |
PJVK
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 59, Autosomal recessive nonsyndromic hearing loss 59 |
| RS1684124082 |
SAMHD1
|
Health Risk |
Pathogenic |
Cerebral palsy, Cerebral palsy |
| RS1684130791 |
TBR1
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with autism and speech delay, Intellectual developmental disorder with autism and speech delay |
| RS1684144086 |
TMEM127
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pheochromocytoma and paraganglioma, Hereditary cancer-predisposing syndrome |
| RS1684145823 |
TMEM127
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pheochromocytoma and paraganglioma, Hereditary cancer-predisposing syndrome |
| RS1684147520 |
TMEM127
|
Health Risk |
Likely pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS1684147771 |
TMEM127
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS1684148846 |
TMEM127
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary cancer-predisposing syndrome |
| RS1684149620 |
TMEM127
|
Health Risk |
Likely pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS1684167000 |
TBR1
|
Health Risk |
Likely pathogenic |
Attention deficit hyperactivity disorder, Autistic behavior |
| RS1684169157 |
TMEM127
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS1684169953 |
TMEM127
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary cancer-predisposing syndrome |
| RS1684180699 |
TBR1
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with autism and speech delay, Intellectual developmental disorder with autism and speech delay |
| RS1684181938 |
TBR1
|
Health Risk |
Likely pathogenic |
Limb myoclonus, Severe global developmental delay |
| RS1684182454 |
TBR1
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with autism and speech delay, Intellectual developmental disorder with autism and speech delay |
| RS1684207130 |
TBR1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1684275626 |
TBR1
|
Health Risk |
Likely pathogenic |
Delayed fine motor development, Severe global developmental delay |
| RS1684388744 |
TMEM127
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary cancer-predisposing syndrome |
| RS1684391372 |
TMEM127
|
Health Risk |
Conflicting classifications of pathogenicity |
Pheochromocytoma, Hereditary pheochromocytoma and paraganglioma |
| RS1684392721 |
TMEM127
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pheochromocytoma and paraganglioma, Hereditary cancer-predisposing syndrome |
| RS1684398953 |
TMEM127
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary cancer-predisposing syndrome |
| RS1684443250 |
POLR1B
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 4, Treacher Collins syndrome |
| RS1684469954 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1684483227 |
KCNH1
|
Health Risk |
Likely pathogenic |
Zimmermann-Laband syndrome 1, Zimmermann-Laband syndrome 1 |
| RS1684563533 |
ATF6
|
Health Risk |
Likely pathogenic |
— |
| RS1684599962 |
LNPK
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum, Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum |
| RS1684627892 |
MERTK
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1684640743 |
ATF6
|
Health Risk |
Likely pathogenic |
— |
| RS1684663181 |
SCN1A
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS1684663586 |
SCN1A
|
Health Risk |
Pathogenic |
Febrile seizures, familial |
| RS1684672231 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS1684673339 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1684678839 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1684680680 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1684687070 |
ST3GAL5
|
Health Risk |
Pathogenic |
GM3 synthase deficiency, GM3 synthase deficiency |
| RS1684688433 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS1684692369 |
ST3GAL5
|
Health Risk |
Pathogenic |
GM3 synthase deficiency, GM3 synthase deficiency |
| RS1684704927 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS1684730153 |
CHN1
|
Health Risk |
Pathogenic |
Autosomal dominant Robinow syndrome 2, Autosomal dominant Robinow syndrome 2 |
| RS1684813071 |
POLR1B
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 4, Treacher Collins syndrome |
| RS1684835050 |
ERCC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Ovarian cancer, Inborn genetic diseases |
| RS1684840786 |
CXCR4
|
Health Risk |
Pathogenic |
Warts, hypogammaglobulinemia |
| RS1684841455 |
CXCR4
|
Health Risk |
Pathogenic |
Warts, hypogammaglobulinemia |
| RS1684842255 |
CXCR4
|
Health Risk |
Pathogenic |
Warts, hypogammaglobulinemia |
| RS1684878263 |
WIPF1
|
Health Risk |
Pathogenic |
Wiskott-Aldrich syndrome 2, Wiskott-Aldrich syndrome 2 |
| RS1684899990 |
HAX1
|
Health Risk |
Pathogenic |
Kostmann syndrome, Kostmann syndrome |
| RS1684901295 |
HAX1
|
Health Risk |
Likely pathogenic |
Kostmann syndrome, Kostmann syndrome |
| RS1684904805 |
HAX1
|
Health Risk |
Likely pathogenic |
Kostmann syndrome, Kostmann syndrome |
| RS1684909842 |
FANCL
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group L, Fanconi anemia |
| RS1684937955 |
MERTK
|
Health Risk |
Likely pathogenic |
— |
| RS16849700 |
BCHE
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of butyrylcholinesterase, Deficiency of butyrylcholinesterase |
| RS1684975294 |
TTC7A
|
Health Risk |
Likely pathogenic |
Multiple gastrointestinal atresias, Multiple gastrointestinal atresias |
| RS1684979540 |
MERTK
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1685036155 |
SLC25A12
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 39 |
| RS1685039783 |
SCN3A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 62 |
| RS1685077018 |
TTC21B
|
Health Risk |
Likely pathogenic |
— |
| RS1685080096 |
TTC21B
|
Health Risk |
Likely pathogenic |
Nephronophthisis 12, Asphyxiating thoracic dystrophy 4 |
| RS1685081916 |
SCN3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS1685164393 |
KYNU
|
Health Risk |
Likely pathogenic |
KYNU-related disorder, KYNU-related disorder |
| RS1685166989 |
FANCL
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group L, Fanconi anemia |
| RS1685168329 |
ATF6
|
Health Risk |
Likely pathogenic |
Achromatopsia 7, Achromatopsia 7 |
| RS1685190008 |
ERCC3
|
Health Risk |
Pathogenic |
— |
| RS1685193967 |
RYR2
|
Health Risk |
Likely pathogenic |
Arrhythmogenic right ventricular dysplasia 2, Arrhythmogenic right ventricular dysplasia 2 |
| RS1685194348 |
GNPAT
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS1685202380 |
ERCC3
|
Health Risk |
Pathogenic |
— |
| RS1685241606 |
B3GALNT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS16852741 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1685339034 |
MERTK
|
Health Risk |
Likely pathogenic |
— |
| RS1685354796 |
ERCC3
|
Health Risk |
Pathogenic |
— |
| RS1685373168 |
GNPAT
|
Health Risk |
Likely pathogenic |
— |
| RS1685487857 |
TTC21B
|
Health Risk |
Likely pathogenic |
Jeune thoracic dystrophy, Nephronophthisis |
| RS1685507024 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS1685514075 |
FANCL
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia complementation group L |
| RS1685540239 |
GNPAT
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS1685554004 |
LRP2
|
Health Risk |
Likely pathogenic |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS1685567937 |
CERKL
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 26, Retinitis pigmentosa 26 |
| RS1685569880 |
TTC21B
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Nephronophthisis |
| RS1685573282 |
CERKL
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1685586746 |
COL5A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1685627126 |
IL36RN
|
Health Risk |
Likely pathogenic |
Generalized pustular psoriasis, Generalized pustular psoriasis |
| RS1685679145 |
GNPAT
|
Health Risk |
Pathogenic |
— |
| RS1685700930 |
ATF6
|
Health Risk |
Likely pathogenic |
— |
| RS16857280 |
DIRC3;DIRC3-AS1
|
Health Risk |
association |
Vascular endothelial growth factor (VEGF) inhibitor response, Vascular endothelial growth factor (VEGF) inhibitor response |
| RS1685730083 |
B3GALNT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS1685734160 |
COL5A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1685781888 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1685782021 |
COL5A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1685785467 |
COL5A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1685786232 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1685876126 |
FANCL
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group L, Fanconi anemia |
| RS1685888740 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS1685908703 |
AGPS
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 3, Rhizomelic chondrodysplasia punctata type 3 |
| RS1685923198 |
COL5A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1686095309 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS1686109678 |
ITGA6
|
Health Risk |
Pathogenic |
— |
| RS1686119579 |
TTC21B
|
Health Risk |
Likely pathogenic |
Jeune thoracic dystrophy, Nephronophthisis |